JournalTOCs

Journal of Enzyme Inhibition and Medicinal Chemistry
Journal Prestige (SJR): 1.04

Citation Impact (citeScore): 3
Number of Followers: 4

This is an Open Access Journal

Open Access journal
ISSN (Print) 1475-6366 - ISSN (Online) 1475-6374
Published by Taylor and Francis

[2600 journals]

Biological exploration of a novel 1,2,4-triazole-indole hybrid molecule as
antifungal agent
- Volume 35, Issue 1, December 2020, Page 398-403
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-01-01T08:00:00Z
  DOI: 10.1080/14756366.2019.1705292
  Issue No: Vol. 35, No. 1 (2020)
Novel CDKs inhibitors for the treatment of solid tumour by simultaneously
regulating the cell cycle and transcription control
- Volume 35, Issue 1, December 2020, Page 414-423
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-01-01T08:00:00Z
  DOI: 10.1080/14756366.2019.1705290
  Issue No: Vol. 35, No. 1 (2020)
Sulphonamides incorporating 1,3,5-triazine structural motifs show
antioxidant, acetylcholinesterase, butyrylcholinesterase, and tyrosinase
inhibitory profile
- Volume 35, Issue 1, December 2020, Page 424-431
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-01-01T08:00:00Z
  DOI: 10.1080/14756366.2019.1707196
  Issue No: Vol. 35, No. 1 (2020)
Design, synthesis, and antiprotozoal evaluation of new
2,4-bis[(substituted-aminomethyl)phenyl]quinoline,
1,3-bis[(substituted-aminomethyl)phenyl]isoquinoline and
2,4-bis[(substituted-aminomethyl)phenyl]quinazoline derivatives
- Volume 35, Issue 1, December 2020, Page 432-459
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-01-01T08:00:00Z
  DOI: 10.1080/14756366.2019.1706502
  Issue No: Vol. 35, No. 1 (2020)
Design, synthesis and cholinesterase inhibitory properties of new oxazole
benzylamine derivatives
- Volume 35, Issue 1, December 2020, Page 460-467
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-01-01T08:00:00Z
  DOI: 10.1080/14756366.2019.1707197
  Issue No: Vol. 35, No. 1 (2020)
Synthesis and biological evaluation of novel (E)-N'-benzylidene hydrazides
as novel c-Met inhibitors through fragment based virtual screening
- Volume 35, Issue 1, December 2020, Page 468-477
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-01-01T08:00:00Z
  DOI: 10.1080/14756366.2019.1702655
  Issue No: Vol. 35, No. 1 (2020)
Synthesis, in vitro screening and molecular docking of
isoquinolinium-5-carbaldoximes as acetylcholinesterase and
butyrylcholinesterase reactivators
- Volume 35, Issue 1, December 2020, Page 478-488
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-01-01T08:00:00Z
  DOI: 10.1080/14756366.2019.1710501
  Issue No: Vol. 35, No. 1 (2020)
Synthesis and human carbonic anhydrase I, II, VA, and XII inhibition with
novel amino acid–sulphonamide conjugates
- Volume 35, Issue 1, December 2020, Page 489-497
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-01-01T08:00:00Z
  DOI: 10.1080/14756366.2019.1710503
  Issue No: Vol. 35, No. 1 (2020)
Development of potent reversible selective inhibitors of
butyrylcholinesterase as fluorescent probes
- Volume 35, Issue 1, December 2020, Page 498-505
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-01-01T08:00:00Z
  DOI: 10.1080/14756366.2019.1710502
  Issue No: Vol. 35, No. 1 (2020)
Sulfocoumarins as dual inhibitors of human carbonic anhydrase isoforms
IX/XII and of human thioredoxin reductase
- Volume 35, Issue 1, December 2020, Page 506-510
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-01-01T08:00:00Z
  DOI: 10.1080/14756366.2020.1712596
  Issue No: Vol. 35, No. 1 (2020)
Deciphering the enzymatic target of a new family of antischistosomal
agents bearing a quinazoline scaffold using complementary computational
tools
- Volume 35, Issue 1, December 2020, Page 511-523
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-01-01T08:00:00Z
  DOI: 10.1080/14756366.2020.1712595
  Issue No: Vol. 35, No. 1 (2020)
Effect of 6-Benzoyl-benzothiazol-2-one scaffold on the pharmacological
profile of α-alkoxyphenylpropionic acid derived PPAR agonists
- Volume 35, Issue 1, December 2020, Page 524-538
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-01-01T08:00:00Z
  DOI: 10.1080/14756366.2020.1713771
  Issue No: Vol. 35, No. 1 (2020)
Coumarins from Magydaris pastinacea as inhibitors of the tumour-associated
carbonic anhydrases IX and XII: isolation, biological studies and in
silico evaluation
- Volume 35, Issue 1, December 2020, Page 539-548
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-01-01T08:00:00Z
  DOI: 10.1080/14756366.2020.1713114
  Issue No: Vol. 35, No. 1 (2020)
A class of carbonic anhydrase IX/XII – selective carboxylate
inhibitors
- Volume 35, Issue 1, December 2020, Page 549-554
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-01-01T08:00:00Z
  DOI: 10.1080/14756366.2020.1715388
  Issue No: Vol. 35, No. 1 (2020)
Design, synthesis and in vitro biological evaluation of quinazolinone
derivatives as EGFR inhibitors for antitumor treatment
- Volume 35, Issue 1, December 2020, Page 555-564
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-01-01T08:00:00Z
  DOI: 10.1080/14756366.2020.1715389
  Issue No: Vol. 35, No. 1 (2020)
Design, synthesis and α-glucosidase inhibition study of novel embelin
derivatives
- Volume 35, Issue 1, December 2020, Page 565-573
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-01-01T08:00:00Z
  DOI: 10.1080/14756366.2020.1715386
  Issue No: Vol. 35, No. 1 (2020)
Selective inhibitors for JNK signalling: a potential targeted therapy in
cancer
- Volume 35, Issue 1, December 2020, Page 574-583
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-01-01T08:00:00Z
  DOI: 10.1080/14756366.2020.1720013
  Issue No: Vol. 35, No. 1 (2020)
C-2 phenyl replacements to obtain potent quinoline-based Staphylococcus
aureus NorA inhibitors
- Volume 35, Issue 1, December 2020, Page 584-597
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-01-01T08:00:00Z
  DOI: 10.1080/14756366.2020.1719083
  Issue No: Vol. 35, No. 1 (2020)
Exploring structure-activity relationship of S-substituted
2-mercaptoquinazolin-4(3H)-one including 4-ethylbenzenesulfonamides as
human carbonic anhydrase inhibitors
- Volume 35, Issue 1, December 2020, Page 598-609
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-01-01T08:00:00Z
  DOI: 10.1080/14756366.2020.1722121
  Issue No: Vol. 35, No. 1 (2020)
Synthesis, anti-inflammatory, cytotoxic, and COX-1/2 inhibitory activities
of cyclic imides bearing 3-benzenesulfonamide, oxime, and β-phenylalanine
scaffolds: a molecular docking study
- Volume 35, Issue 1, December 2020, Page 610-621
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-01-01T08:00:00Z
  DOI: 10.1080/14756366.2020.1722120
  Issue No: Vol. 35, No. 1 (2020)
Bioorganometallic derivatives of 4-hydrazino-benzenesulphonamide as
carbonic anhydrase inhibitors: synthesis, characterisation and biological
evaluation
- Volume 35, Issue 1, December 2020, Page 622-628
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-02-10T11:49:49Z
  DOI: 10.1080/14756366.2020.1724995
  Issue No: Vol. 35, No. 1 (2020)
Aspartic peptidase of Phialophora verrucosa as target of HIV peptidase
inhibitors: blockage of its enzymatic activity and interference with
fungal growth and macrophage interaction
- Volume 35, Issue 1, December 2020, Page 629-638
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-02-10T11:32:58Z
  DOI: 10.1080/14756366.2020.1724994
  Issue No: Vol. 35, No. 1 (2020)
Discovery of small molecule inhibitors of Leishmania braziliensis Hsp90
chaperone
- Volume 35, Issue 1, December 2020, Page 639-649
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-02-12T12:18:36Z
  DOI: 10.1080/14756366.2020.1726342
  Issue No: Vol. 35, No. 1 (2020)
7-Acylamino-3H-1,2-benzoxathiepine 2,2-dioxides as new isoform-selective
carbonic anhydrase IX and XII inhibitors
- Volume 35, Issue 1, December 2020, Page 650-656
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-02-21T09:54:14Z
  DOI: 10.1080/14756366.2020.1722658
  Issue No: Vol. 35, No. 1 (2020)
In vivo antiaging effects of alkaline water supplementation
- Volume 35, Issue 1, December 2020, Page 657-664
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-02-28T07:05:46Z
  DOI: 10.1080/14756366.2020.1733547
  Issue No: Vol. 35, No. 1 (2020)
Combining carbonic anhydrase and thioredoxin reductase inhibitory motifs
within a single molecule dramatically increases its cytotoxicity
- Volume 35, Issue 1, December 2020, Page 665-671
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-03-05T08:53:59Z
  DOI: 10.1080/14756366.2020.1734800
  Issue No: Vol. 35, No. 1 (2020)
Examination of sulfonamide-based inhibitors of MMP3 using the conditioned
media of invasive glioma cells
- Volume 35, Issue 1, December 2020, Page 672-681
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-03-11T08:21:30Z
  DOI: 10.1080/14756366.2020.1715387
  Issue No: Vol. 35, No. 1 (2020)
Design, synthesis and antifungal activity of threoninamide carbamate
derivatives via pharmacophore model
- Volume 35, Issue 1, December 2020, Page 682-691
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-03-09T11:25:29Z
  DOI: 10.1080/14756366.2020.1729144
  Issue No: Vol. 35, No. 1 (2020)
Synthesis and characterisation of thiobarbituric acid enamine derivatives,
and evaluation of their α-glucosidase inhibitory and anti-glycation
activity
- Volume 35, Issue 1, December 2020, Page 692-701
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-03-11T08:15:27Z
  DOI: 10.1080/14756366.2020.1737045
  Issue No: Vol. 35, No. 1 (2020)
Synthesis, biological evaluation and molecular modelling of
2,4-disubstituted-5-(6-alkylpyridin-2-yl)-1H-imidazoles as ALK5 inhibitors
- Volume 35, Issue 1, December 2020, Page 702-712
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-03-13T06:53:36Z
  DOI: 10.1080/14756366.2020.1734799
  Issue No: Vol. 35, No. 1 (2020)
Discovery of novel ATAD2 bromodomain inhibitors that trigger apoptosis and
autophagy in breast cells by structure-based virtual screening
- Volume 35, Issue 1, December 2020, Page 713-725
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-03-16T11:04:30Z
  DOI: 10.1080/14756366.2020.1740924
  Issue No: Vol. 35, No. 1 (2020)
Histidine residues at the copper-binding site in human tyrosinase are
essential for its catalytic activities
- Volume 35, Issue 1, December 2020, Page 726-732
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-03-17T11:29:38Z
  DOI: 10.1080/14756366.2020.1740691
  Issue No: Vol. 35, No. 1 (2020)
S-substituted 2-mercaptoquinazolin-4(3H)-one and 4-ethylbenzensulfonamides
act as potent and selective human carbonic anhydrase IX and XII inhibitors
- Volume 35, Issue 1, December 2020, Page 733-743
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-03-19T10:05:43Z
  DOI: 10.1080/14756366.2020.1742117
  Issue No: Vol. 35, No. 1 (2020)
Synthesis, antitumor activity, and molecular docking study of
2-cyclopentyloxyanisole derivatives: mechanistic study of enzyme
inhibition
- Volume 35, Issue 1, December 2020, Page 744-758
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-03-18T08:41:21Z
  DOI: 10.1080/14756366.2020.1740695
  Issue No: Vol. 35, No. 1 (2020)
Antiproliferative chromone derivatives induce K562 cell death through
endogenous and exogenous pathways
- Volume 35, Issue 1, December 2020, Page 759-772
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-03-18T08:37:43Z
  DOI: 10.1080/14756366.2020.1740696
  Issue No: Vol. 35, No. 1 (2020)
Design, synthesis and anticancer activity of naphthoquinone derivatives
- Volume 35, Issue 1, December 2020, Page 773-785
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-03-23T07:13:23Z
  DOI: 10.1080/14756366.2020.1740693
  Issue No: Vol. 35, No. 1 (2020)
Unveiling the interaction profile of rosmarinic acid and its bioactive
substructures with serum albumin
- Volume 35, Issue 1, December 2020, Page 786-804
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-03-23T07:09:58Z
  DOI: 10.1080/14756366.2020.1740923
  Issue No: Vol. 35, No. 1 (2020)
Synthesis and biological evaluation of 3-arylbenzofuranone derivatives as
potential anti-Alzheimer’s disease agents
- Volume 35, Issue 1, December 2020, Page 805-814
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-03-18T08:47:21Z
  DOI: 10.1080/14756366.2020.1740694
  Issue No: Vol. 35, No. 1 (2020)
Exploring the fatty acid amide hydrolase and cyclooxygenase inhibitory
properties of novel amide derivatives of ibuprofen
- Volume 35, Issue 1, December 2020, Page 815-823
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-03-23T07:09:03Z
  DOI: 10.1080/14756366.2020.1743283
  Issue No: Vol. 35, No. 1 (2020)
Activation studies of the β-carbonic anhydrases from Malassezia restricta
with amines and amino acids
- Volume 35, Issue 1, December 2020, Page 824-830
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-03-27T08:09:04Z
  DOI: 10.1080/14756366.2020.1743284
  Issue No: Vol. 35, No. 1 (2020)
Antitumor properties of certain spirooxindoles towards hepatocellular
carcinoma endowed with antioxidant activity
- Volume 35, Issue 1, December 2020, Page 831-839
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-03-25T08:50:58Z
  DOI: 10.1080/14756366.2020.1743281
  Issue No: Vol. 35, No. 1 (2020)
Intra-site differential inhibition of multi-specific enzymes
- Volume 35, Issue 1, December 2020, Page 840-846
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-03-25T08:56:59Z
  DOI: 10.1080/14756366.2020.1743988
  Issue No: Vol. 35, No. 1 (2020)
Design, synthesis, molecular modelling and biological evaluation of novel
3-(2-naphthyl)-1-phenyl-1H-pyrazole derivatives as potent antioxidants and
15-Lipoxygenase inhibitors
- Volume 35, Issue 1, December 2020, Page 847-863
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-03-27T08:06:54Z
  DOI: 10.1080/14756366.2020.1742116
  Issue No: Vol. 35, No. 1 (2020)
2-Thiopyrimidine/chalcone hybrids: design, synthesis, ADMET prediction,
and anticancer evaluation as STAT3/STAT5a inhibitors
- Volume 35, Issue 1, December 2020, Page 864-879
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-03-25T08:45:03Z
  DOI: 10.1080/14756366.2020.1740922
  Issue No: Vol. 35, No. 1 (2020)
Synthesis and biological evaluation of
(3/4-(pyrimidin-2-ylamino)benzoyl)-based
hydrazine-1-carboxamide/carbothioamide derivatives as novel RXRα
antagonists
- Volume 35, Issue 1, December 2020, Page 880-896
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-03-30T09:50:25Z
  DOI: 10.1080/14756366.2020.1740692
  Issue No: Vol. 35, No. 1 (2020)
Strong inhibitory activities and action modes of lipopeptides on lipase
- Volume 35, Issue 1, December 2020, Page 897-905
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-03-27T08:03:42Z
  DOI: 10.1080/14756366.2020.1734798
  Issue No: Vol. 35, No. 1 (2020)
The selenium-containing drug ebselen potently disrupts LEDGF/p75-HIV-1
integrase interaction by targeting LEDGF/p75
- Volume 35, Issue 1, December 2020, Page 906-912
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-03-31T08:09:36Z
  DOI: 10.1080/14756366.2020.1743282
  Issue No: Vol. 35, No. 1 (2020)
Use of an immobilised thermostable α-CA (SspCA) for enhancing the
metabolic efficiency of the freshwater green microalga Chlorella
sorokiniana
- Volume 35, Issue 1, December 2020, Page 913-920
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-03-30T09:58:10Z
  DOI: 10.1080/14756366.2020.1746785
  Issue No: Vol. 35, No. 1 (2020)
Novel sulindac derivatives: synthesis, characterisation, evaluation of
antioxidant, analgesic, anti-inflammatory, ulcerogenic and COX-2
inhibition activity
- Volume 35, Issue 1, December 2020, Page 921-934
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-04-02T09:21:29Z
  DOI: 10.1080/14756366.2020.1746783
  Issue No: Vol. 35, No. 1 (2020)
Imidazopyridine-fused [1,3]diazepinones: modulations of positions 2 to 4
and their impacts on the anti-melanoma activity
- Volume 35, Issue 1, December 2020, Page 935-949
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-04-06T06:18:06Z
  DOI: 10.1080/14756366.2020.1748024
  Issue No: Vol. 35, No. 1 (2020)
Synthesis, characterisation, biological evaluation and in silico studies
of sulphonamide Schiff bases
- Volume 35, Issue 1, December 2020, Page 950-962
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-04-06T05:56:54Z
  DOI: 10.1080/14756366.2020.1746784
  Issue No: Vol. 35, No. 1 (2020)
Lipidomic analysis of cancer cells cultivated at acidic pH reveals
phospholipid fatty acids remodelling associated with transcriptional
reprogramming
- Volume 35, Issue 1, December 2020, Page 963-973
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-04-20T10:03:43Z
  DOI: 10.1080/14756366.2020.1748025
  Issue No: Vol. 35, No. 1 (2020)
6,7-Dimethoxy-2-phenethyl-1,2,3,4-tetrahydroisoquinoline amides and
corresponding ester isosteres as multidrug resistance reversers
- Volume 35, Issue 1, December 2020, Page 974-992
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-04-07T09:37:21Z
  DOI: 10.1080/14756366.2020.1747449
  Issue No: Vol. 35, No. 1 (2020)
1,2,4-Triazole-based anticonvulsant agents with additional ROS scavenging
activity are effective in a model of pharmacoresistant epilepsy
- Volume 35, Issue 1, December 2020, Page 993-1002
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-04-07T09:43:15Z
  DOI: 10.1080/14756366.2020.1748026
  Issue No: Vol. 35, No. 1 (2020)
Synthesis and carbonic anhydrase activating properties of a series of
2-amino-imidazolines structurally related to clonidine1
- Volume 35, Issue 1, December 2020, Page 1003-1010
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-04-27T07:16:18Z
  DOI: 10.1080/14756366.2020.1749602
  Issue No: Vol. 35, No. 1 (2020)
The antibiotic furagin and its derivatives are isoform-selective human
carbonic anhydrase inhibitors
- Volume 35, Issue 1, December 2020, Page 1011-1020
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-04-16T10:05:46Z
  DOI: 10.1080/14756366.2020.1752201
  Issue No: Vol. 35, No. 1 (2020)
Preparation, carbonic anhydrase enzyme inhibition and antioxidant activity
of novel 7-amino-3,4-dihydroquinolin-2(1H)-one derivatives incorporating
mono or dipeptide moiety
- Volume 35, Issue 1, December 2020, Page 1021-1026
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-04-16T09:49:29Z
  DOI: 10.1080/14756366.2020.1751620
  Issue No: Vol. 35, No. 1 (2020)
An overview on natural farnesyltransferase inhibitors for efficient cancer
therapy
- Volume 35, Issue 1, December 2020, Page 1027-1044
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-04-20T10:01:35Z
  DOI: 10.1080/14756366.2020.1732366
  Issue No: Vol. 35, No. 1 (2020)
Inhibition of African swine fever virus protease by myricetin and
myricitrin
- Volume 35, Issue 1, December 2020, Page 1045-1049
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-04-17T07:33:41Z
  DOI: 10.1080/14756366.2020.1754813
  Issue No: Vol. 35, No. 1 (2020)
Antiproliferative benzothiazoles incorporating a trimethoxyphenyl scaffold
as novel colchicine site tubulin polymerisation inhibitors
- Volume 35, Issue 1, December 2020, Page 1050-1059
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-04-17T07:21:47Z
  DOI: 10.1080/14756366.2020.1753721
  Issue No: Vol. 35, No. 1 (2020)
Bacterial ι-carbonic anhydrase: a new active class of carbonic anhydrase
identified in the genome of the Gram-negative bacterium Burkholderia
territorii
- Volume 35, Issue 1, December 2020, Page 1060-1068
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-04-21T09:51:26Z
  DOI: 10.1080/14756366.2020.1755852
  Issue No: Vol. 35, No. 1 (2020)
Hybrid inhibitors of DNA and HDACs remarkably enhance cytotoxicity in
leukaemia cells
- Volume 35, Issue 1, December 2020, Page 1069-1079
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-04-21T09:48:52Z
  DOI: 10.1080/14756366.2020.1754812
  Issue No: Vol. 35, No. 1 (2020)
Chemical approaches for the enhancement of porphyrin skeleton-based
photodynamic therapy
- Volume 35, Issue 1, December 2020, Page 1080-1099
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-04-24T09:24:30Z
  DOI: 10.1080/14756366.2020.1755669
  Issue No: Vol. 35, No. 1 (2020)
Synthesis and biological evaluation of new 3(2H)-pyridazinone derivatives
as non-toxic anti-proliferative compounds against human colon carcinoma
HCT116 cells
- Volume 35, Issue 1, December 2020, Page 1100-1109
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-04-23T05:00:57Z
  DOI: 10.1080/14756366.2020.1755670
  Issue No: Vol. 35, No. 1 (2020)
Discovery of 5-methyl-N-(2-arylquinazolin-7-yl)isoxazole-4-carboxamide
analogues as highly selective FLT3 inhibitors
- Volume 35, Issue 1, December 2020, Page 1110-1115
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-04-27T09:52:39Z
  DOI: 10.1080/14756366.2020.1758689
  Issue No: Vol. 35, No. 1 (2020)
Design, synthesis and in vitro antiproliferative activity of new
thiazolidinedione-1,3,4-oxadiazole hybrids as thymidylate synthase
inhibitors
- Volume 35, Issue 1, December 2020, Page 1116-1123
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-05-01T04:40:47Z
  DOI: 10.1080/14756366.2020.1759581
  Issue No: Vol. 35, No. 1 (2020)
Biochemical mechanism and biological effects of the inhibition of silent
information regulator 1 (SIRT1) by EX-527 (SEN0014196 or selisistat)
- Volume 35, Issue 1, December 2020, Page 1124-1136
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-05-05T07:07:32Z
  DOI: 10.1080/14756366.2020.1758691
  Issue No: Vol. 35, No. 1 (2020)
Repurposing strategies on pyridazinone-based series by pharmacophore- and
structure-driven screening
- Volume 35, Issue 1, December 2020, Page 1137-1144
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-05-05T11:02:06Z
  DOI: 10.1080/14756366.2020.1760261
  Issue No: Vol. 35, No. 1 (2020)
Natural compounds as inhibitors of transthyretin amyloidosis and
neuroprotective agents: analysis of structural data for future drug design
- Volume 35, Issue 1, December 2020, Page 1145-1162
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-05-18T11:19:39Z
  DOI: 10.1080/14756366.2020.1760262
  Issue No: Vol. 35, No. 1 (2020)
Recent progress in the development of steroid sulphatase inhibitors –
examples of the novel and most promising compounds from the last decade
- Volume 35, Issue 1, December 2020, Page 1163-1184
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-05-04T10:35:49Z
  DOI: 10.1080/14756366.2020.1758692
  Issue No: Vol. 35, No. 1 (2020)
The Carbonic Anhydrase IX inhibitor SLC-0111 as emerging agent against the
mesenchymal stem cell-derived pro-survival effects on melanoma cells
- Volume 35, Issue 1, December 2020, Page 1185-1193
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-05-12T11:43:49Z
  DOI: 10.1080/14756366.2020.1764549
  Issue No: Vol. 35, No. 1 (2020)
Oxy-imino saccharidic derivatives as a new structural class of aldose
reductase inhibitors endowed with anti-oxidant activity
- Volume 35, Issue 1, December 2020, Page 1194-1205
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-05-12T11:37:46Z
  DOI: 10.1080/14756366.2020.1763331
  Issue No: Vol. 35, No. 1 (2020)
Carbonic anhydrase modulation of emotional memory. Implications for the
treatment of cognitive disorders
- Volume 35, Issue 1, December 2020, Page 1206-1214
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-05-13T02:24:31Z
  DOI: 10.1080/14756366.2020.1766455
  Issue No: Vol. 35, No. 1 (2020)
Synthesis of calix[4]azacrown substituted sulphonamides with antioxidant,
acetylcholinesterase, butyrylcholinesterase, tyrosinase and carbonic
anhydrase inhibitory action
- Volume 35, Issue 1, December 2020, Page 1215-1223
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-05-13T02:23:22Z
  DOI: 10.1080/14756366.2020.1765166
  Issue No: Vol. 35, No. 1 (2020)
Discovery and antibacterial study of potential PPK1 inhibitors against
uropathogenic E. coli
- Volume 35, Issue 1, December 2020, Page 1224-1232
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-05-18T12:39:13Z
  DOI: 10.1080/14756366.2020.1766453
  Issue No: Vol. 35, No. 1 (2020)
A nanobody-derived mimotope against VEGF inhibits cancer angiogenesis
- Volume 35, Issue 1, December 2020, Page 1233-1239
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-05-22T10:59:37Z
  DOI: 10.1080/14756366.2020.1758690
  Issue No: Vol. 35, No. 1 (2020)
Discovery of secondary sulphonamides as IDO1 inhibitors with potent
antitumour effects in vivo
- Volume 35, Issue 1, December 2020, Page 1240-1257
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-05-29T06:59:15Z
  DOI: 10.1080/14756366.2020.1765165
  Issue No: Vol. 35, No. 1 (2020)
Prognostic value of CAIX expression in oral squamous cell carcinoma: a
systematic review and meta-analysis
- Volume 35, Issue 1, December 2020, Page 1258-1266
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-05-29T07:40:40Z
  DOI: 10.1080/14756366.2020.1772250
  Issue No: Vol. 35, No. 1 (2020)
Recent advances in modulators of circadian rhythms: an update and
perspective
- Volume 35, Issue 1, December 2020, Page 1267-1286
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-06-08T08:34:38Z
  DOI: 10.1080/14756366.2020.1772249
  Issue No: Vol. 35, No. 1 (2020)
Screening of ninety herbal products of commercial interest as potential
ingredients for phytocosmetics
- Volume 35, Issue 1, December 2020, Page 1287-1291
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-06-09T01:32:05Z
  DOI: 10.1080/14756366.2020.1774571
  Issue No: Vol. 35, No. 1 (2020)
Biochemical and structural characterisation of a protozoan beta-carbonic
anhydrase from Trichomonas vaginalis
- Volume 35, Issue 1, December 2020, Page 1292-1299
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-06-09T01:35:14Z
  DOI: 10.1080/14756366.2020.1774572
  Issue No: Vol. 35, No. 1 (2020)
Novel [(N-alkyl-3-indolylmethylene)hydrazono]oxindoles arrest cell cycle
and induce cell apoptosis by inhibiting CDK2 and Bcl-2: synthesis,
biological evaluation and in silico studies
- Volume 35, Issue 1, December 2020, Page 1300-1309
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-06-11T08:52:54Z
  DOI: 10.1080/14756366.2020.1773814
  Issue No: Vol. 35, No. 1 (2020)
Design, synthesis, and anticonvulsant effects evaluation of nonimidazole
histamine H3 receptor antagonists/inverse agonists containing triazole
moiety
- Volume 35, Issue 1, December 2020, Page 1310-1321
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-06-12T12:21:36Z
  DOI: 10.1080/14756366.2020.1774573
  Issue No: Vol. 35, No. 1 (2020)
Advances in the discovery of exosome inhibitors in cancer
- Volume 35, Issue 1, December 2020, Page 1322-1330
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-06-16T04:06:57Z
  DOI: 10.1080/14756366.2020.1754814
  Issue No: Vol. 35, No. 1 (2020)
Synthesis and evaluation of a large library of nitroxoline derivatives as
pancreatic cancer antiproliferative agents
- Volume 35, Issue 1, December 2020, Page 1331-1344
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-06-26T09:53:29Z
  DOI: 10.1080/14756366.2020.1780228
  Issue No: Vol. 35, No. 1 (2020)
Mechanistic and biological characterisation of novel N5-substituted
paullones targeting the biosynthesis of trypanothione in Leishmania
- Volume 35, Issue 1, December 2020, Page 1345-1358
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-06-26T09:48:40Z
  DOI: 10.1080/14756366.2020.1780227
  Issue No: Vol. 35, No. 1 (2020)
The effects of cardiac drugs on human erythrocyte carbonic anhydrase I and
II isozymes
- Volume 35, Issue 1, December 2020, Page 1359-1362
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-06-22T11:48:07Z
  DOI: 10.1080/14756366.2020.1781844
  Issue No: Vol. 35, No. 1 (2020)
Topoisomerases inhibition and DNA binding mode of
daunomycin–oligoarginine conjugate
- Volume 35, Issue 1, December 2020, Page 1363-1371
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-06-19T07:16:34Z
  DOI: 10.1080/14756366.2020.1780226
  Issue No: Vol. 35, No. 1 (2020)
Cinnamic acid derivatives: inhibitory activity against Escherichia coli
β-glucuronidase and structure–activity relationships
- Volume 35, Issue 1, December 2020, Page 1372-1378
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-06-23T04:57:36Z
  DOI: 10.1080/14756366.2020.1780225
  Issue No: Vol. 35, No. 1 (2020)
Activation studies of the β-carbonic anhydrases from Escherichia coli
with amino acids and amines
- Volume 35, Issue 1, December 2020, Page 1379-1386
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-06-24T07:44:48Z
  DOI: 10.1080/14756366.2020.1781845
  Issue No: Vol. 35, No. 1 (2020)
Design, synthesis, and in vitro evaluation of aza-peptide aldehydes and
ketones as novel and selective protease inhibitors
- Volume 35, Issue 1, December 2020, Page 1387-1402
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-07-07T09:56:50Z
  DOI: 10.1080/14756366.2020.1781107
  Issue No: Vol. 35, No. 1 (2020)
Novel piperidine derivatives as colchicine binding site inhibitors induce
apoptosis and inhibit epithelial-mesenchymal transition against prostate
cancer PC3 cells
- Volume 35, Issue 1, December 2020, Page 1403-1413
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-06-26T09:48:57Z
  DOI: 10.1080/14756366.2020.1783664
  Issue No: Vol. 35, No. 1 (2020)
A study of Rose Bengal against a 2-keto-3-deoxy-d-manno-octulosonate
cytidylyltransferase as an antibiotic candidate
- Volume 35, Issue 1, December 2020, Page 1414-1421
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-06-26T09:47:47Z
  DOI: 10.1080/14756366.2020.1751150
  Issue No: Vol. 35, No. 1 (2020)
Synthesis, in vitro enzyme activity and molecular docking studies of new
benzylamine-sulfonamide derivatives as selective MAO-B inhibitors
- Volume 35, Issue 1, December 2020, Page 1422-1432
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-06-30T12:16:04Z
  DOI: 10.1080/14756366.2020.1784892
  Issue No: Vol. 35, No. 1 (2020)
LC-QTOF-MS analysis of xanthone content in different parts of Garcinia
mangostana and its influence on cholinesterase inhibition
- Volume 35, Issue 1, December 2020, Page 1433-1441
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-07-01T09:03:21Z
  DOI: 10.1080/14756366.2020.1786819
  Issue No: Vol. 35, No. 1 (2020)
Synthesis, computational studies and assessment of in vitro inhibitory
activity of umbelliferon-based compounds against tumour-associated
carbonic anhydrase isoforms IX and XII
- Volume 35, Issue 1, December 2020, Page 1442-1449
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-07-02T04:30:25Z
  DOI: 10.1080/14756366.2020.1786821
  Issue No: Vol. 35, No. 1 (2020)
Human carbonic anhydrases and post-translational modifications: a hidden
world possibly affecting protein properties and functions
- Volume 35, Issue 1, December 2020, Page 1450-1461
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-07-10T10:17:36Z
  DOI: 10.1080/14756366.2020.1781846
  Issue No: Vol. 35, No. 1 (2020)
Coumarin carbonic anhydrase inhibitors from natural sources
- Volume 35, Issue 1, December 2020, Page 1462-1470
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-08-11T09:21:23Z
  DOI: 10.1080/14756366.2020.1788009
  Issue No: Vol. 35, No. 1 (2020)
Synthesis and structure-activity relationships of novel 5-(hydroxamic
acid)methyl oxazolidinone derivatives as 5-lipoxygenase inhibitors
- Volume 35, Issue 1, December 2020, Page 1471-1482
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-07-08T07:28:55Z
  DOI: 10.1080/14756366.2020.1786082
  Issue No: Vol. 35, No. 1 (2020)
Synthesis and evaluation of 2,4,5-trisubstitutedthiazoles as carbonic
anhydrase-III inhibitors
- Volume 35, Issue 1, December 2020, Page 1483-1490
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-07-08T07:30:57Z
  DOI: 10.1080/14756366.2020.1786820
  Issue No: Vol. 35, No. 1 (2020)
Novel heterocyclic hybrids of pyrazole targeting dihydrofolate reductase:
design, biological evaluation and in silico studies
- Volume 35, Issue 1, December 2020, Page 1491-1502
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-07-16T07:39:02Z
  DOI: 10.1080/14756366.2020.1791842
  Issue No: Vol. 35, No. 1 (2020)
Synthesis and structure-activity relationships of cerebroside analogues as
substrates of cerebroside sulphotransferase and discovery of a competitive
inhibitor
- Volume 35, Issue 1, December 2020, Page 1503-1512
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-07-13T09:51:08Z
  DOI: 10.1080/14756366.2020.1791841
  Issue No: Vol. 35, No. 1 (2020)
Design, synthesis, and evaluation of 1, 4-benzodioxan-substituted
chalcones as selective and reversible inhibitors of human monoamine
oxidase B
- Volume 35, Issue 1, December 2020, Page 1513-1523
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-07-24T05:26:54Z
  DOI: 10.1080/14756366.2020.1797711
  Issue No: Vol. 35, No. 1 (2020)
Design, synthesis and biological evaluation of novel tetrahydrothieno
[2,3-c]pyridine substitued benzoyl thiourea derivatives as PAK1 inhibitors
in triple negative breast cancer
- Volume 35, Issue 1, December 2020, Page 1524-1538
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-08-05T06:25:20Z
  DOI: 10.1080/14756366.2020.1797710
  Issue No: Vol. 35, No. 1 (2020)
Flavonoids with inhibitory activity against SARS-CoV-2 3CLpro
- Volume 35, Issue 1, December 2020, Page 1539-1544
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-08-04T07:10:25Z
  DOI: 10.1080/14756366.2020.1801672
  Issue No: Vol. 35, No. 1 (2020)
Escherichia coli γ-carbonic anhydrase: characterisation and effects of
simple aromatic/heterocyclic sulphonamide inhibitors
- Volume 35, Issue 1, December 2020, Page 1545-1554
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-08-04T07:10:08Z
  DOI: 10.1080/14756366.2020.1800670
  Issue No: Vol. 35, No. 1 (2020)
Inhibitory activity against carbonic anhydrase IX and XII as a candidate
selection criterion in the development of new anticancer agents
- Volume 35, Issue 1, December 2020, Page 1555-1561
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-08-04T07:11:42Z
  DOI: 10.1080/14756366.2020.1801674
  Issue No: Vol. 35, No. 1 (2020)
Functionality study of chalcone-hydroxypyridinone hybrids as tyrosinase
inhibitors and influence on anti-tyrosinase activity
- Volume 35, Issue 1, December 2020, Page 1562-1567
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-08-04T07:12:24Z
  DOI: 10.1080/14756366.2020.1801669
  Issue No: Vol. 35, No. 1 (2020)
Discovery of N-(1-(3-fluorobenzoyl)-1H-indol-5-yl)pyrazine-2-carboxamide:
a novel, selective, and competitive indole-based lead inhibitor for human
monoamine oxidase B
- Volume 35, Issue 1, December 2020, Page 1568-1580
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-08-05T06:37:03Z
  DOI: 10.1080/14756366.2020.1800666
  Issue No: Vol. 35, No. 1 (2020)
Cytotoxic substituted indolizines as new colchicine site tubulin
polymerisation inhibitors
- Volume 35, Issue 1, December 2020, Page 1581-1595
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-08-05T06:39:08Z
  DOI: 10.1080/14756366.2020.1801671
  Issue No: Vol. 35, No. 1 (2020)
Design, synthesis and biological evaluation of edaravone derivatives
bearing the N-benzyl pyridinium moiety as multifunctional
anti-Alzheimer’s agents
- Volume 35, Issue 1, December 2020, Page 1596-1605
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-08-11T09:41:23Z
  DOI: 10.1080/14756366.2020.1801673
  Issue No: Vol. 35, No. 1 (2020)
Identification of probe-quality degraders for Poly(ADP-ribose)
polymerase-1 (PARP-1)
- Volume 35, Issue 1, December 2020, Page 1606-1615
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-08-11T02:10:22Z
  DOI: 10.1080/14756366.2020.1804382
  Issue No: Vol. 35, No. 1 (2020)
Discovery of 3,6-disubstituted pyridazines as a novel class of anticancer
agents targeting cyclin-dependent kinase 2: synthesis, biological
evaluation and in silico insights
- Volume 35, Issue 1, December 2020, Page 1616-1630
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-08-12T06:52:03Z
  DOI: 10.1080/14756366.2020.1806259
  Issue No: Vol. 35, No. 1 (2020)
Potential anti-neuroinflammatory NF-кB inhibitors based on
3,4-dihydronaphthalen-1(2H)-one derivatives
- Volume 35, Issue 1, December 2020, Page 1631-1640
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-08-12T06:45:59Z
  DOI: 10.1080/14756366.2020.1804899
  Issue No: Vol. 35, No. 1 (2020)
Design, synthesis and biological evaluation of a new
thieno[2,3-d]pyrimidine-based urea derivative with potential antitumor
activity against tamoxifen sensitive and resistant breast cancer cell
lines
- Volume 35, Issue 1, December 2020, Page 1641-1656
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-08-12T06:44:22Z
  DOI: 10.1080/14756366.2020.1804383
  Issue No: Vol. 35, No. 1 (2020)
Synthesis, anticancer evaluation and molecular docking studies of new
benzimidazole- 1,3,4-oxadiazole derivatives as human topoisomerase types I
poison
- Volume 35, Issue 1, December 2020, Page 1657-1673
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-08-19T07:14:24Z
  DOI: 10.1080/14756366.2020.1806831
  Issue No: Vol. 35, No. 1 (2020)
Efficient synthesis, biological evaluation, and docking study of isatin
based derivatives as caspase inhibitors
- Volume 35, Issue 1, December 2020, Page 1674-1684
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-08-26T05:54:31Z
  DOI: 10.1080/14756366.2020.1809388
  Issue No: Vol. 35, No. 1 (2020)
New classes of potent heparanase inhibitors from ligand-based virtual
screening
- Volume 35, Issue 1, December 2020, Page 1685-1696
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-09-10T05:44:09Z
  DOI: 10.1080/14756366.2020.1811701
  Issue No: Vol. 35, No. 1 (2020)
The intensification of anticancer activity of LFM-A13 by erythropoietin as
a possible option for inhibition of breast cancer
- Volume 35, Issue 1, December 2020, Page 1697-1711
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-09-11T06:15:25Z
  DOI: 10.1080/14756366.2020.1818738
  Issue No: Vol. 35, No. 1 (2020)
Imidazothiazole-based potent inhibitors of V600E-B-RAF kinase with
promising anti-melanoma activity: biological and computational studies
- Volume 35, Issue 1, December 2020, Page 1712-1726
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-09-23T07:34:12Z
  DOI: 10.1080/14756366.2020.1819260
  Issue No: Vol. 35, No. 1 (2020)
Rational design of small molecules able to inhibit α-synuclein amyloid
aggregation for the treatment of Parkinson’s disease
- Volume 35, Issue 1, December 2020, Page 1727-1735
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-09-14T10:19:56Z
  DOI: 10.1080/14756366.2020.1816999
  Issue No: Vol. 35, No. 1 (2020)
Thiazolidin-2-cyanamides derivatives as novel potent Escherichia coli
β-glucuronidase inhibitors and their structure–inhibitory activity
relationships
- Volume 35, Issue 1, December 2020, Page 1736-1742
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-09-15T05:31:16Z
  DOI: 10.1080/14756366.2020.1816998
  Issue No: Vol. 35, No. 1 (2020)
Quetiapine and novel PDE10A inhibitors potentiate the anti-BuChE activity
of donepezil
- Volume 35, Issue 1, December 2020, Page 1743-1750
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-09-17T08:49:12Z
  DOI: 10.1080/14756366.2020.1818739
  Issue No: Vol. 35, No. 1 (2020)
Novel temporin L antimicrobial peptides: promoting self-assembling by
lipidic tags to tackle superbugs
- Volume 35, Issue 1, December 2020, Page 1751-1764
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-09-22T07:11:30Z
  DOI: 10.1080/14756366.2020.1819258
  Issue No: Vol. 35, No. 1 (2020)
Toxicity evaluation of sulfamides and coumarins that efficiently inhibit
human carbonic anhydrases
- Volume 35, Issue 1, December 2020, Page 1765-1772
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-09-18T04:16:58Z
  DOI: 10.1080/14756366.2020.1822829
  Issue No: Vol. 35, No. 1 (2020)
Characterisation of naturally occurring isothiocyanates as glutathione
reductase inhibitors
- Volume 35, Issue 1, December 2020, Page 1773-1780
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-09-21T04:57:04Z
  DOI: 10.1080/14756366.2020.1822828
  Issue No: Vol. 35, No. 1 (2020)
DNA topoisomerases as molecular targets for anticancer drugs
- Volume 35, Issue 1, December 2020, Page 1781-1799
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-09-25T10:47:38Z
  DOI: 10.1080/14756366.2020.1821676
  Issue No: Vol. 35, No. 1 (2020)
The structural basis for the selectivity of sulfonamido dicarbaboranes
toward cancer-associated carbonic anhydrase IX
- Volume 35, Issue 1, December 2020, Page 1800-1810
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-09-23T07:33:44Z
  DOI: 10.1080/14756366.2020.1816996
  Issue No: Vol. 35, No. 1 (2020)
Hydroxypropyl-β-cyclodextrin as an effective carrier of curcumin –
piperine nutraceutical system with improved enzyme inhibition properties
- Volume 35, Issue 1, December 2020, Page 1811-1821
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-09-24T06:43:09Z
  DOI: 10.1080/14756366.2020.1801670
  Issue No: Vol. 35, No. 1 (2020)
Structure-activity relationship of 7-aryl-2-anilino-pyrrolopyrimidines as
Mer and Axl tyrosine kinase inhibitors
- Volume 35, Issue 1, December 2020, Page 1822-1833
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-09-25T04:18:47Z
  DOI: 10.1080/14756366.2020.1825407
  Issue No: Vol. 35, No. 1 (2020)
Sulphonamide inhibition profile of Staphylococcus aureus β-carbonic
anhydrase
- Volume 35, Issue 1, December 2020, Page 1834-1839
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-09-25T04:28:38Z
  DOI: 10.1080/14756366.2020.1826942
  Issue No: Vol. 35, No. 1 (2020)
Design of new disubstituted imidazo[1,2-b]pyridazine derivatives as
selective Haspin inhibitors. Synthesis, binding mode and anticancer
biological evaluation
- Volume 35, Issue 1, December 2020, Page 1840-1853
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-10-12T07:29:12Z
  DOI: 10.1080/14756366.2020.1825408
  Issue No: Vol. 35, No. 1 (2020)
Design, synthesis, and evaluation of novel
N'-substituted-1-(4-chlorobenzyl)-1H-indol-3-carbohydrazides as antitumor
agents
- Volume 35, Issue 1, December 2020, Page 1854-1865
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-09-28T07:32:32Z
  DOI: 10.1080/14756366.2020.1816997
  Issue No: Vol. 35, No. 1 (2020)
Inhibition mechanism of naphthylphenylamine derivatives acting on the
CDC25B dual phosphatase and analysis of the molecular processes involved
in the high cytotoxicity exerted by one selected derivative in melanoma
cells
- Volume 35, Issue 1, December 2020, Page 1866-1878
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-09-29T09:43:33Z
  DOI: 10.1080/14756366.2020.1819257
  Issue No: Vol. 35, No. 1 (2020)
Synthesis, in vitro inhibitory activity, kinetic study and molecular
docking of novel N-alkyl–deoxynojirimycin derivatives as potential
α-glucosidase inhibitors
- Volume 35, Issue 1, December 2020, Page 1879-1890
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-10-02T06:58:27Z
  DOI: 10.1080/14756366.2020.1826941
  Issue No: Vol. 35, No. 1 (2020)
Novel insights on saccharin- and acesulfame-based carbonic anhydrase
inhibitors: design, synthesis, modelling investigations and biological
activity evaluation
- Volume 35, Issue 1, December 2020, Page 1891-1905
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-10-02T07:02:36Z
  DOI: 10.1080/14756366.2020.1828401
  Issue No: Vol. 35, No. 1 (2020)
Investigation of pesticides on honey bee carbonic anhydrase inhibition
- Volume 35, Issue 1, December 2020, Page 1923-1927
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-10-20T10:16:15Z
  DOI: 10.1080/14756366.2020.1835885
  Issue No: Vol. 35, No. 1 (2020)
Synthesis and biological activity of 2-cyanoacrylamide derivatives
tethered to imidazopyridine as TAK1 inhibitors
- Volume 35, Issue 1, December 2020, Page 1928-1936
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-10-22T07:57:31Z
  DOI: 10.1080/14756366.2020.1833876
  Issue No: Vol. 35, No. 1 (2020)
Multidirectional in vitro and in cellulo studies as a tool for
identification of multi-target-directed ligands aiming at symptoms and
causes of Alzheimer’s disease
- Volume 35, Issue 1, December 2020, Page 1944-1952
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-10-23T06:31:04Z
  DOI: 10.1080/14756366.2020.1835882
  Issue No: Vol. 35, No. 1 (2020)
An overview of carbohydrate-based carbonic anhydrase inhibitors
- .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-10-20T10:12:58Z
  DOI: 10.1080/14756366.2020.1825409